Serums Clinical Trial

MMBalance, MMRepose, MMRevive

The purpose of this IRB approved biomedical research study was to determine and measure benefits from 13 subjects with twice daily use of MMSkincare serums over a 12-week period. The serums include MMBalance to treat acne-prone skin, MMRepose to treat rhytides (fine lines) and dull skin, and MMRevive to treat UV damage, hyperpigmentation, rosacea, and inflamed skin. Results were measured at 4 weeks and at 12 weeks via qualitative as well as quantitative data using photographic artificial intelligence analysis.

MMBALANCE SUBJECTS

62%

MMBalance Subjects:
After 30 days of regular use, 62% of subjects saw an improvement in acne

BEFORE / AFTERS

MMREPOSE SUBJECTS

92%

After 30 days of regular use, 92% of participants saw an improvement in overall complexion and skin texture.

53%

53.3% of subjects reported a decrease in rhytides (fine lines) from baseline to week 12.

BEFORE / AFTERS

MMREVIVE SUBJECTS

42%

After 30 days of regular use, 42% of subjects reported an improvement in epidermal inflammation

46%

After 30 days of regular use, 46% of subjects reported an improvement in skin sensitivity

62%

62.7% of subjects reported a decrease in skin dyspigmentation from baseline to week 12

BEFORE / AFTERS